Resistance profile of An. gambiae from Bassila and Djougou
The mortality of the mosquitoes in each insecticide bioassay is presented in Fig. 1 and Additional file 1. There was a significant difference in the mortality rate between mosquitoes from Bassila and mosquitoes from Djougou (P < 0.05). Mosquitoes from Djougou were more resistant to alphacypermethrin and deltamethrin than mosquitoes from Bassila. At 1X exposure to alphacypermethrin and deltamethrin, the average percent mortality in Djougou was zero, while it was 77.5% (sd: 2.28) for alphacypermethrin and 65.5% (sd: 3.03) for deltamethrin in Bassila. At 2X exposure, the average percent mortality in Djougou was 46.7% (sd: 1.06) and 26.68% (sd: 2.5) for alphacypermethrin and deltamethrin, respectively, and in Bassila, it was 82.8% (sd: 0.1) and 80% (sd: 5.54), respectively. At 5X exposure, the average percent mortality in Djougou was 77.4% (sd: 1.65) and 50.8% (sd: 2.98) for alphacypermethrin and deltamethrin, respectively, and 100% and 86.8% (sd: 0.72) in Bassila (Additional file 1).
In contrast to the pyrethroids, mosquitoes from Bassila were more resistant than mosquitoes from Djougou when tested against pirimiphos-methyl. The mortality at 1X exposure was 22.0% (sd: 0.31) in Djougou and 2.1% (sd: 0.58) in Bassila. At 1.5X exposure, the mortality was 75.2% (sd: 1.66) in Djougou and 26.3% (sd: 3.81) in Bassila (Additional file 1).
RNA-Seq data quality control and mapping
Raw reads generated ranged from 45–112 million for mosquitoes from Bassila, 51–108 million for mosquitoes from Djougou and 77–102 million for the susceptible Kisumu strain mosquitoes. After filtering, more than 98% of the reads were retained in all experiments and mapped to the whole reference genome of Anopheles gambiae PEST (VectorBase release 48). The percentage of reads mapped to the reference genome ranged between 61% and 70.6% for Bassila, 51.4% and 76% for Djougou and 69.2% and 75% for the susceptible Kisumu strain (Additional file 2), and 70% and 79% of the alignments (read pairs) were successfully assigned to the exonic features of the gene set AgamP4 (Additional file 3).
Differential gene expression analysis
EdgeR was used to perform differential gene expression (DGE) analysis between the different mosquito groups (R-S), (C-S) and (R-C). A fold-change (FC) > 2 and a false discovery rate (FDR) < 0.01 were used to identify differentially expressed genes (Fig. 2). The DGE results are summarized in Table 1 and Additional file 4.
Table 1
Differential gene expression summary for alphacypermethrin, deltamethrin and pirimiphos-methyl
Insecticide | Site | Condition | Number of genes tested | DE genes (|FC|>2 & adjP < 0.05) | DE genes (|FC|>2 & adjP < 0.01) |
UP | Down | UP | Down |
Alphacypermethrin | Djougou | DA vs DU (R-C) | 9743 | 31 | 30 | 13 | 12 |
DA vs KIS (R-S) | 10041 | 949 | 860 | 850 | 755 |
Deltamethrin | Bassila | BD vs BU (R-C) | 9920 | 41 | 65 | 28 | 47 |
BD vs KIS (R-S) | 10146 | 966 | 819 | 943 | 805 |
Djougou | DD vs DU (R-C) | 9937 | 68 | 24 | 45 | 17 |
DD vs KIS (R-S) | 10154 | 887 | 573 | 822 | 555 |
Pirimiphos-methyl | Bassila | BP vs BU (R-C) | 9740 | 12 | 50 | 8 | 39 |
BP vs KIS (R-S) | 10080 | 968 | 776 | 926 | 758 |
Djougou | DP vs DU (R-C) | 9571 | 94 | 114 | 55 | 81 |
DP vs KIS (R-S) | 9979 | 953 | 764 | 932 | 750 |
Unexposed | Bassila | BU vs KIS (C-S) | 9999 | 886 | 696 | 863 | 686 |
Djougou | DU vs KIS (C-S) | 10014 | 757 | 609 | 698 | 576 |
Differential gene expression associated with alphacypermethrin.
Genes associated with alphacypermethrin resistance were derived from three different comparisons using mosquitoes from Djougou. A total of 1274 genes (698 upregulated and 576 downregulated), 1605 genes (850 upregulated and 755 downregulated) and 25 genes (13 upregulated and 12 downregulated) were significantly differentially expressed in the C-S, R-S and R-C comparisons, respectively (Table 1). A total of 4 key upregulated genes were shared between the three comparison sets, with only one characterized protein belonging to the cuticular protein RR-1 family 75 (Additional file 5-A). Comparing R-S and C-S comparisons, genes overexpressed in both sets are shown in (Additional file 6). Interestingly, a carboxylesterase (COE22933), some cuticular proteins (CPR76, CPR75, CPR16, TWDL1, CPR81, and CPAP3-A1b), some members of the cytochrome P450 family (CYP4D17, and CYP12F2) and some salivary gland proteins (salivary secreted peptide (AGAP013060), kDa salivary (AGAP004316)) showed higher fold changes in the R-S comparison compared to the C-S comparison. Along with these genes, DE-cadherin-like isoform X1 (AGAP029696), COX2, TEP1, ESP, methyltransferase 22 isoform X1 (AGAP011879), microfibril-associated glyco 4-like (AGAP010531) and BTB/POZ domain-containing protein KCTD16 (AGAP000805) also showed higher fold changes in the R-S set of genes (Additional file 6). Importantly, a comparison between the R-S and R-C groups available in (Additional file 7) showed that the cuticular protein (CPR75) and the carboxylesterases (COEunkn) were differentially expressed and shared among both comparisons.
Focusing on R-S comparisons, carboxylesterases (COE12O, COEunkn, and COEBE3C), cuticular proteins (CPAP3-A1c, CPAP3-A1a, and CPAP3-D), cytochrome P450s (CYP12F3, CYP306A1, and CYP4G16), salivary gland proteins (salivary secreted mucin 3 (AGAP009473), secreted salivary gland (AGAP001989)), and an odorant-binding protein (AGAP012867) were overexpressed and were not significantly expressed in the C-S set of genes (Additional file 6, Fig. 3). Additionally, other genes (FC ~ 11.2-380.5) overexpressed in the R-S set of genes were related to neuronal acetylcholine receptor subunit non-alpha-3-like (AGAP010169), autophagy 12-like (AGAP012847), DE-cadherin-like isoform X1 (AGAP029698), antigen 5 like allergen Cul n 1-like (AGAP006417) or NADH dehydrogenase subunit 6 (AGAP028386), and CEC1 (Additional file 6).
Differential gene expression associated with deltamethrin
In Bassila, 1549 genes (863 upregulated and 686 downregulated), 1748 genes (943 upregulated and 805 downregulated) and 75 genes (28 upregulated and 47 downregulated) were significantly differentially expressed in C-S, R-S and R-C comparisons, respectively (Table 1). No DEGs were shared between the three groups (Additional file 5-B). In Djougou, the number of DEGs significantly differentially expressed in the C-S, R-S and R-C comparisons were 1274 genes (698 upregulated and 576 downregulated), 1377 genes (822 upregulated and 555 downregulated) and 62 genes (45 upregulated and 17 downregulated), respectively (Table 1). Unlike in Bassila, five DEGs were upregulated and shared between the three groups (Additional file 5-C). Among them, two had retrievable annotations and were related to SERAC1 isoform X1 (AGAP011044) and serine protease (CLIPB5).
A total of 1240 DEGs (661 upregulated and 579 downregulated) and 887 DEGs (506 upregulated and 381 downregulated) were shared between the R-S and C-S groups from Bassila and Djougou, respectively. The DEGs in Bassila included a carboxylesterase (COE120), five cuticular proteins (CPCFC1, CPR125, CPR140, and CPLCG5), two cytochrome P450s (CYP9M1, and CYP6P2), two glutathione S-transferases (GSTE2, and GSTE4) and six salivary gland proteins (D7r2, SG7, SG3, SG1c, D7L1, and D7L2) with markedly higher expression in the R-S group compared to the C-S group. In Djougou, 7 cuticular proteins (CPAP3-A1b, CPR76, TWDL1, CPAP3-B, CPR81, CPR75, and CPAP3-E), 3 cytochrome P450s (CYP6AA2, CYP12F2, and CYP6Z3) and a salivary gland protein (SG2) exhibited higher expression in the R-S group than in the C-S group (Additional file 6, Fig. 3). Other DEGs with higher expression in the R-S group than in the C-S group were related to TEP9, GNBPB4, indirect flight muscle (AGAP011514), and an apyrase-like (AGAP005457) in Bassila, and St1, CLIPB5, TEP4, ESP, CLIPC7, and glycine-rich 5-like (AGAP001508), SERAC1 isoform X1 (AGAP011044), and myrosinase 1-like (AGAP006426) in Djougou (Additional file 6).
Comparing the R-S and R-C groups, CYP6Z3 in Bassila, and CPR9, CPR144 and CYP4H24 in Djougou were shared among both comparisons. In addition, the angiopoietin-like salivary protein (AGAP007041) in Bassila and CYP314A1 in Djougou were overexpressed in only the R-C group, together with other genes such as fibrinogen A (AGAP011228), CLIPB12, PPO6, and PGRPLB in Djougou (Additional file 7).
Focusing on DEGs within the R-S group, a total of 951 (546 upregulated and 405 downregulated) genes were commonly differentially expressed in deltamethrin survivors from both the Bassila and Djougou populations relative to the susceptible strain (Fig. 4-A). The upregulated genes included one carboxylesterase (COEJHE5E), seven cuticular proteins (CPLCP3, CPR130, CPR30, CPR59, CPAP3-B, CPR76, and TWDL1), five cytochrome P450s (CYP4H15, CYP12F2, CYP6Z3, CYP9K1, and CYP9M1), three glutathione S-transferases (GSTE2, GSTD7, and GSTE4), a salivary gland protein (SG2), and an odorant binding protein (OBP47). Interestingly, the detoxification genes CYP12F2 and CYP6Z3 exhibited higher transcription activity in deltamethrin survivors from Djougou (FC = 33.6 & 24.3 respectively) than in those from Bassila (FC = 15.1 & 6.7 respectively), suggesting their potential association with the differing levels of resistance between these two field populations (Additional file 8, Fig. 3).
Differential gene expression associated with pirimiphos-methyl
Differentially expressed genes in Bassila included 1549 genes (863 upregulated and 686 downregulated), 1684 genes (926 upregulated and 758 downregulated) and 47 genes (8 upregulated and 39 downregulated) in C-S, R-S and R-C respectively (Table 1). However, in Djougou, 1274 genes (698 upregulated and 576 downregulated), 1682 genes (932 upregulated and 750 downregulated) and 136 genes (55 upregulated and 81 downregulated) were differentially expressed in C-S, R-S and R-C, respectively (Table 1).
In Bassila, a total of 1220 DEGs (665 upregulated and 555 downregulated) were shared between the R-S and C-S groups (Additional file 5-D). Some of them exhibited higher fold change expression in the R-S group than in the C-S group, and these included four cuticular proteins (CPR16, CPR30, CPLCG5, and CPCFC1), six cytochrome P450s (CYP9M1, CYP6Z2, CYP6P3, CYP6Z3, CYP307A1, and CYP12F2), two glutathione S-transferases (GSTS1, and GSTD7) and two salivary gland proteins (SG7, and SG9) (Additional file 6). In Djougou, 982 DEGs (545 upregulated and 437 downregulated) were shared between the R-S and C-S comparisons (Additional file 5-E). From these DEGs, those that exhibited higher fold changes included one carboxylesterase (COE22933), seven cuticular proteins (CPR30, CPR76, CPR16, CPLCG1, CPR81, CPLCX2, and CPAP3-E), seven cytochrome P450s (CYP6M2, CYP6P3, CYP6Z3, CYP4D22, CYP9K1, CYP6AA2, and CYP6Z2), two glutathione S-transferases (GSTE2, and GSTD7), two salivary gland proteins (SG7, and SG9) and one odorant binding protein (OBP25) (Fig. 3). Other DEGs with retrievable annotations were two trypsin-related proteases (TRYP7, and AGAP012842), a glycine-rich cell wall structural-like (AGAP008892) and others (Additional file 6).
Comparing the R-S and R-C groups, no metabolic genes were shared among the two comparisons in Bassila, while CYP6Z3 and GSTD11 were shared in Djougou. Additionally, two carboxylesterases (AGAP011507, COEAE2E), PPO6, PPO9, PGRPLB, and fibrinogen A (AGAP011228) were overexpressed in only the R-C group in Djougou (Additional file 7).
Focusing on the DEGs in the R-S group, a total of 1191 DEGs (665 upregulated and 526 downregulated) were commonly differentially expressed in the pirimiphos-methyl survivors from both Bassila and Djougou when compared to the susceptible strain (Fig. 4-B). These shared DEGs included two carboxylesterases (COE22933, and COEJHE5E), 11 cuticular proteins (CPLCG5, CPR130, CPR30, CPCFC1, CPR76, CPR75, CPAP3-B, CPR127, CPR15, CPR16, and CPR144), seven cytochrome P450s (CYP6Z3, CYP12F2, CYP6M2, CYP9K1, CYP6P4, CYP6P3, and CYP6Z2), three glutathione S-transferases (GSTD7, GSTE2, and GSTE4), four salivary gland proteins (SG7, SG2, SG9, and salivary cysteine-rich peptide (AGAP011460)), and two odorant binding proteins (OBP47, OBP26) (Additional file 8, Fig. 3).
Genes associated with multiple insecticide resistance
A total of 500 DEGs (265 upregulated and 235 downregulated) were shared by mosquitoes that survived exposure to either alphacypermethrin, deltamethrin or pirimiphos-methyl (Fig. 5-A, Additional file 9). Among those genes, 10 were cuticular proteins (CPAP3-B, CPAP3-E, CPR10, CPR130, CPR15, CPR16, CPR30, CPR75, CPR76, and CPR81), 8 were cytochrome P450s (CYP12F2, CYP307A1, CYP4C26, CYP4C27, CYP6Z3, CYP9J3, CYP9K1, and CYP9L3), 3 were glutathione S- transferases (GSTD7, GSTE2, and GSTMS3) and 3 were undefined salivary gland protein genes Fig. 5-C, Table 2).
Table 2
Significantly differentially expressed genes of interest in R–S and C–S (FDR < 0.01 and FC > 2)
Gene categories | Gene type | Gene ID | Gene Symbol | FC (DA_KIS) | FC (BD_KIS) | FC (DD_KIS) | FC (BP_KIS) | FC (DP_KIS) | FC (BU_KIS) | FC (DU_KIS) |
Detoxification genes | Carboxylesterase genes (COE) | AGAP010390 | COE12O | NS | 4,37 | NS | NS | NS | 4,21 | NS |
AGAP003568 | COE22933 | 2,77 | NS | NS | NS | 2,17 | NS | 2,17 |
AGAP005372 | COEBE3C | NS | 2,09 | NS | NS | NS | 2,34 | NS |
AGAP005837 | COEJHE5E | NS | 2,27 | 2,47 | 2,27 | 3,34 | 2,84 | 3,34 |
AGAP013509 | | 0,38 | NS | NS | NS | NS | NS | 0,37 |
Cytochrome P450s genes (CYPs) | AGAP002429 | CYP314A1 | NS | NS | NS | NS | 0,19 | NS | 0,19 |
AGAP000192 | CYP4C26 | 0,09 | 0,26 | 0,18 | 0,12 | 0,09 | 0,30 | 0,09 |
AGAP009246 | CYP4C27 | 2,92 | 3,52 | 2,39 | 2,08 | 2,12 | 3,73 | 2,12 |
AGAP009240 | CYP4C35 | NS | 3,09 | NS | NS | NS | 2,58 | NS |
AGAP009241 | CYP4C36 | 0,37 | NS | NS | NS | 0,40 | NS | 0,40 |
AGAP008358 | CYP4H17 | 2,45 | NS | NS | NS | NS | NS | 3,09 |
AGAP002419 | CYP4D22 | NS | 2,14 | NS | 2,22 | 3,96 | 2,00 | 3,96 |
AGAP001864 | CYP4H15 | 4,84 | 5,54 | 4,79 | 3,35 | NS | 5,35 | 5,39 |
AGAP013128 | CYP6AA2 | NS | NS | 2,37 | 2,55 | 2,68 | 2,48 | 2,68 |
AGAP010961 | CYP6AK1 | 0,28 | 0,38 | 0,29 | NS | NS | 0,45 | 0,41 |
AGAP008020 | CYP12F2 | 38,07 | 15,11 | 33,64 | 31,97 | 29,82 | 27,46 | 29,82 |
AGAP012957 | CYP4D17 | 3,76 | NS | NS | NS | NS | NS | 2,03 |
AGAP005992 | CYP302A1 | 0,27 | NS | 0,25 | NS | 0,38 | NS | 0,38 |
AGAP002869 | CYP6P2 | NS | 2,64 | NS | NS | NS | 2,07 | NS |
AGAP010077 | CYP303A1 | NS | NS | NS | NS | 14,07 | NS | 14,07 |
AGAP008212 | CYP6M2 | NS | NS | NS | 6,44 | 5,47 | 5,81 | 5,47 |
AGAP001039 | CYP307A1 | 0,35 | 0,15 | 0,45 | 0,20 | 0,27 | 0,17 | 0,27 |
AGAP002865 | CYP6P3 | 2,08 | 2,66 | NS | 4,58 | 4,79 | 3,10 | 4,79 |
AGAP000818 | CYP9K1 | 2,34 | 3,85 | 6,26 | 6,06 | 10,41 | 7,22 | 10,41 |
AGAP002867 | CYP6P4 | NS | 6,77 | NS | 4,59 | 6,55 | 6,07 | 6,55 |
AGAP009374 | CYP9M1 | NS | 3,14 | NS | 3,92 | NS | 2,46 | NS |
AGAP012295 | CYP9L1 | 0,43 | NS | NS | NS | NS | NS | 0,49 |
AGAP012293 | CYP9L3 | 0,37 | 0,43 | 0,21 | 0,40 | 0,29 | 0,45 | 0,29 |
AGAP012296 | CYP9J5 | 0,40 | NS | NS | NS | 0,48 | NS | 0,48 |
AGAP012291 | CYP9J3 | 0,35 | 0,41 | 0,47 | 0,30 | 0,26 | 0,39 | 0,26 |
AGAP008217 | CYP6Z3 | 23,07 | NS | 24,26 | 36,86 | NS | 26,13 | 23,99 |
AGAP008218 | CYP6Z2 | 3,09 | NS | 2,90 | 4,21 | 5,43 | 2,82 | 5,43 |
Glutathione S-transferase genes (GSTs) | AGAP009193 | GSTE4 | NS | 3,29 | NS | 2,13 | NS | 2,81 | NS |
AGAP004164 | GSTD1-4 | NS | 0,45 | NS | 0,47 | NS | 0,50 | NS |
AGAP009194 | GSTE2 | 2,69 | 6,20 | 3,24 | 3,95 | 3,58 | 4,90 | 3,58 |
AGAP009946 | GSTMS3 | 2,53 | 2,94 | 3,27 | 4,13 | 4,71 | 3,37 | 4,71 |
AGAP010404 | GSTS1 | NS | 2,85 | NS | 3,26 | NS | 2,56 | NS |
AGAP004163 | GSTD7 | 3,18 | 3,56 | 2,80 | 5,62 | 3,95 | 4,54 | 3,95 |
Cuticullar proteins | CPs | AGAP009790 | CPAP3-B | 2,71 | 5,92 | 3,57 | 4,39 | 3,63 | 4,74 | 3,63 |
AGAP000047 | CPR130 | 4,88 | 19,51 | 3,98 | 13,03 | 6,58 | 15,36 | 6,58 |
AGAP007980 | CPCFC1 | NS | 20,16 | NS | 11,36 | NS | 10,78 | NS |
AGAP008444 | CPLCG1 | 0,25 | 2,06 | NS | NS | 0,49 | 2,08 | 0,49 |
AGAP008447 | CPLCG4 | NS | 32,11 | NS | 25,61 | NS | 31,88 | NS |
AGAP009405 | CPAP3-E | 2,37 | 2,54 | 3,03 | 3,13 | 3,84 | 3,51 | 3,84 |
AGAP003334 | CPLCX2 | 0,29 | NS | 0,19 | NS | 0,36 | NS | 0,36 |
AGAP009759 | CPLCP12 | NS | 9,51 | NS | 7,10 | NS | 8,66 | NS |
AGAP000987 | CPAP3-A1b | 2,66 | NS | 3,47 | NS | NS | NS | 2,20 |
AGAP001664 | CPR1 | NS | NS | NS | NS | 9,26 | NS | 9,26 |
AGAP002994 | CPR10 | 2,53 | 2,44 | 2,03 | 2,38 | 2,91 | 2,45 | 2,91 |
AGAP000820 | CPR125 | NS | 3,83 | NS | NS | NS | 2,44 | NS |
AGAP008449 | CPLCG5 | NS | 41,81 | NS | 32,75 | NS | 30,06 | NS |
AGAP009758 | CPLCP11 | NS | 3,91 | NS | NS | NS | 3,66 | NS |
AGAP000344 | CPR127 | 2,99 | 4,68 | NS | 4,15 | 2,53 | 4,21 | 2,53 |
AGAP003308 | CPAP3-C | NS | 3,95 | NS | NS | NS | 3,60 | NS |
AGAP006868 | CPR140 | NS | 7,06 | NS | 2,86 | NS | 4,55 | NS |
AGAP005456 | CPR15 | 3,62 | 3,67 | 2,97 | 4,03 | 3,85 | 4,60 | 3,85 |
AGAP005459 | CPR16 | 5,53 | 3,04 | 2,57 | 4,57 | 4,28 | 3,56 | 4,28 |
AGAP006829 | CPR59 | NS | 6,40 | NS | NS | NS | 5,64 | NS |
AGAP006283 | CPR70 | NS | NS | NS | 0,41 | NS | 0,39 | NS |
AGAP009871 | CPR75 | NS | 2,79 | 2,45 | 4,72 | 2,73 | 4,63 | 2,73 |
AGAP009874 | CPR76 | 9,99 | 5,24 | 5,27 | 7,87 | 7,67 | 8,71 | 7,67 |
AGAP011937 | | NS | 5,15 | NS | 2,37 | NS | 4,40 | NS |
AGAP006009 | CPR30 | 4,07 | 5,72 | 4,13 | 10,52 | 12,52 | 9,04 | 12,52 |
AGAP006369 | CPR144 | NS | NS | NS | 4,53 | NS | 4,83 | NS |
AGAP011936 | | NS | 2,32 | NS | NS | NS | 2,24 | NS |
AGAP008512 | | NS | 2,24 | NS | 2,06 | NS | 2,04 | NS |
AGAP001748 | | NS | 3,62 | NS | 3,03 | NS | 3,57 | NS |
AGAP000352 | TWDL1 | 3,52 | NS | 3,43 | NS | NS | NS | 2,64 |
AGAP009879 | CPR81 | 2,86 | 3,35 | 2,66 | 3,29 | 3,53 | 3,51 | 3,53 |
AGAP002726 | CPR9 | NS | 2,82 | NS | NS | NS | 2,33 | NS |
Salivary gland proteins | SGPs | AGAP008216 | SG7 | NS | 4,48 | NS | 5,53 | NS | 2,40 | NS |
AGAP008279 | D7L2 | NS | 2,94 | NS | NS | NS | 2,25 | NS |
AGAP008282 | D7r2 | NS | 4,78 | NS | NS | NS | 2,43 | NS |
AGAP008278 | D7L1 | NS | 4,42 | NS | NS | NS | 3,35 | NS |
AGAP008280 | D7r5 | 0,31 | NS | NS | NS | 0,46 | NS | 0,46 |
AGAP000612 | SG1 | 0,41 | NS | 0,39 | NS | NS | NS | 0,42 |
AGAP003841 | SG10 | 0,07 | NS | NS | 0,29 | 0,20 | 0,48 | 0,20 |
AGAP000607 | SG1c | NS | 2,78 | NS | NS | NS | 2,08 | NS |
AGAP003713 | | NS | NS | NS | NS | 0,43 | NS | 0,43 |
AGAP006507 | SG3 | NS | 4,59 | NS | NS | NS | 3,25 | NS |
AGAP013423 | SG9 | NS | NS | NS | 2,51 | 2,62 | 2,07 | 2,62 |
AGAP006899 | | NS | 2,02 | NS | NS | NS | 2,08 | NS |
AGAP006442 | | 0,21 | NS | 0,46 | NS | 0,47 | NS | 0,47 |
AGAP006506 | SG2 | NS | 4,29 | 3,59 | 3,49 | 2,95 | 3,69 | 2,95 |
AGAP007851 | | 2,28 | NS | 2,32 | 4,15 | 4,28 | 3,51 | 4,28 |
AGAP013060 | | 7,62 | 3,92 | 4,31 | 4,20 | 5,47 | 4,72 | 5,47 |
AGAP000152 | | NS | NS | 0,27 | NS | 0,40 | NS | 0,40 |
AGAP008782 | | NS | NS | NS | 2,81 | NS | 2,79 | NS |
AGAP001989 | | NS | 3,79 | NS | 2,07 | NS | 2,82 | NS |
AGAP005822 | | NS | 2,82 | NS | NS | NS | 2,29 | NS |
AGAP011026 | | NS | 2,76 | NS | 3,03 | NS | 2,37 | NS |
AGAP012926 | | 21,96 | 21,98 | 34,61 | 18,38 | 34,50 | 30,36 | 34,50 |
AGAP006495 | | 0,22 | NS | 0,22 | NS | 0,35 | NS | 0,35 |
AGAP004316 | | 5,75 | 10,10 | 9,75 | 5,32 | NS | 11,86 | 4,92 |
AGAP006432 | | NS | NS | NS | NS | 0,45 | NS | 0,45 |
Non-synonymous target site mutations
Target site mutations in the Ace-1 and in the kdr genes were identified through the analysis of single nucleotide polymorphisms (SNPs). The analyzed samples were composed of pools of seven mosquitoes, and a single population included three replicates (pools). The frequency at which polymorphisms appeared in a population was derived from the depth coverage at each position with the contribution of each mosquito in the pools. We found the G280S mutant allele frequency in the Ace-1 gene to be 50% for Bassila compared to 66% for Djougou (Fig. 6). For the kdr gene, we observed the L995F mutation in 33% of samples from Bassila and 100% of samples from Djougou. Other mutations observed in that gene are shown in Fig. 6.
Gene ontology annotation and enrichment analysis
Gene ontology enrichment (GOE) analysis was conducted on differentially expressed genes (up and downregulated) for all R-S comparisons. Gene ontologies are classified into three classes: biological process (BP), molecular function (MF) and cellular component (CC) (Additional file 10).
Among BP GO terms, terms related to proton transport (GO:0015986), aerobic respiration (GO:0009060) and mitochondrial electron transport (GO:0006123, GO:0006120) were shared in the BD vs KIS, BP vs KIS, DD vs KIS and DP vs KIS comparisons. Furthermore, GO terms associated with glycolytic processes (GO:0006096) were enriched in BP vs KIS and DP vs KIS; while the carbohydrate metabolic processes (GO:0005975) were enriched in BD vs KIS and DD vs KIS (Additional file 11). Considering the CC GO terms, terms associated with mitochondrial respiratory chain complex I (GO:0005747) III (GO:0005750) and IV(GO:0005751) were enriched in BD vs KIS, BP vs KIS, DD vs KIS and DP vs KIS with mitochondrial proton-transporting ATP synthase complex, and coupling factor F(o) (GO:0000276) was enriched in only the BP vs KIS and DP vs KIS comparisons (Additional file 11). Concerning terms related to MF, macromolecular complex binding related terms (GO:0044877) and sulfur cluster binding (GO:0051539) were enriched in all R-S comparisons except DA vs KIS. Hydrogen ion transmembrane transporter activity (GO:0015078) was enriched in both BP and DP vs KIS, highlighting its strong correlation with exposure to pirimiphos-methyl (Additional file 11).
RNA-Seq data validation using quantitative PCR
The expression patterns of four genes (SG7, CYP9K1, CYP6P3 and COEJHE5E) were validated in relation to two housekeeping genes (40S ribosomal protein S7; RPS7 and Actin5c) (Fig. 7). Most of the qPCR results supported the directionality of the expression level changes observed after RNA sequencing. Nevertheless, for the COEJHE5E gene, while downexpression was observed in DP vs KIS after qPCR, an overexpression was observed in the RNA-seq dataset.